infecti
diseas
believ
caus
approxim
annual
death
virus
caus
deadliest
pandem
record
human
histori
includ
influenza
pandem
million
death
hivaid
pandem
million
death
far
emerg
pathogen
subsequ
spread
made
signific
impact
global
health
well
econom
loss
interrupt
trade
chang
variou
environment
biolog
socioeconom
polit
expans
intern
travel
trade
extend
reach
increas
rate
viral
infecti
diseas
prompt
need
rapid
outbreak
detect
effici
monitor
spread
minim
burden
global
health
economi
blood
consid
mine
inform
play
import
role
immun
system
averag
entir
volum
blood
circul
throughout
human
bodi
everi
minut
carri
nearli
realtim
inform
statu
viral
transport
blood
cell
nutrient
oxygen
metabol
product
pathogen
throughout
bodi
case
mani
infecti
addit
blood
complex
mixtur
well
special
type
connect
tissu
live
blood
cell
erythrocyt
leukocyt
platelet
suspend
nonliv
fluid
matrix
plasma
upon
centrifug
blood
separ
variou
compon
base
densiti
reddish
mass
bottom
consist
erythrocyt
whole
blood
volum
thin
whitish
layer
buffi
coat
consist
leukocyt
platelet
less
blood
volum
less
dens
plasma
make
remain
whole
blood
top
although
blood
plasma
strawcolor
sticki
fluid
mostli
water
contain
differ
dissolv
solut
plasma
protein
account
weight
plasma
volum
abund
plasma
solut
plasma
protein
includ
albumin
plasma
protein
globulin
plasma
protein
clot
protein
plasma
protein
other
includ
metabol
enzym
except
bloodborn
hormon
gamma
globulin
plasma
protein
produc
liver
composit
plasma
vari
continu
substanc
ad
remov
blood
cell
plasma
without
clot
protein
fibrinogen
call
serum
mani
compon
drift
along
blood
may
help
defend
bodi
foreign
invad
bacteria
virus
although
sampl
eg
urin
saliva
stool
sweat
use
blood
plasma
serum
univers
prefer
sampl
viral
infecti
diseas
diagnosi
despit
complex
blood
stabl
environ
compar
saliva
urin
human
bodi
regul
balanc
blood
compon
maintain
physiolog
steadi
state
howev
viru
relat
compon
extrem
rare
fundament
challeng
viru
viral
biomark
detect
current
diagnost
test
viral
infect
includ
viru
isol
direct
detect
identif
viral
nucleic
acid
antigen
serolog
test
involv
detect
virusspecif
viru
expand
viral
cultur
vitro
small
sampl
tissu
suspici
fluid
inocul
special
tube
along
monolay
relev
cell
line
viral
cultur
usual
requir
minimum
day
provid
statist
signific
viru
identif
confirm
either
immunofluoresc
detect
hemagglutin
assay
although
diagnost
approach
viral
isol
laborintens
timeconsum
still
remain
necessari
techniqu
provid
viabl
isol
use
character
phenotyp
antivir
suscept
addit
rapid
viral
nuclei
acid
immunoglobulin
ig
protein
test
commerci
avail
commerci
kit
conduct
dna
rna
extract
viral
tissu
blood
sampl
follow
molecular
detect
immunofluoresc
stain
use
monoclon
antibodi
polymeras
chain
reaction
pcr
gel
immunoassay
enzymelink
immunosorb
assay
elisa
use
detect
endogen
virusspecif
igm
antibodi
produc
combat
viral
newer
diagnost
techniqu
realtim
quantit
pcr
qpcr
assay
also
appli
viral
detect
qpcr
detect
offer
high
specif
sensit
target
particular
fragment
region
particular
viral
howev
abovement
qpcr
elisa
method
consist
seri
step
includ
sampl
prepar
incub
purif
amplif
detect
thu
order
avoid
fals
result
highli
train
personnel
requir
also
special
laboratori
facil
accord
colleg
american
pathologist
pointofcar
test
refer
test
design
use
near
site
patient
locat
requir
perman
dedic
space
perform
outsid
physic
facil
clinic
laboratori
learn
histor
infecti
diseas
outbreak
death
resourc
consumpt
grow
exponenti
without
effect
world
health
organ
develop
assur
criteria
success
pointofcar
platform
expect
satisfi
set
requir
includ
afford
sensit
specif
user
friendli
rapid
robust
equipmentfre
howev
sever
challeng
exist
develop
technolog
viral
analysi
blood
sampl
earli
stage
viral
infect
concentr
target
virion
biomark
usual
extrem
thu
high
sensit
specif
requir
viru
detect
system
improv
signaltonois
ratio
enrich
normal
need
detect
captur
viru
viral
relat
biomark
remov
major
interf
compon
also
rariti
target
suffici
sampl
volum
necessari
guarante
adequ
number
target
sampl
theoret
limit
one
target
molecul
particl
sampl
volum
microfluid
devic
normal
limit
microlit
rang
requir
sampl
volum
larg
either
devic
satur
rapidli
process
time
unrealist
long
addit
realworld
sampl
use
worldtochip
interfac
problem
includ
sampl
load
onchip
manipul
obvious
weak
link
need
analysi
speed
also
critic
factor
test
infecti
diseas
ideal
receiv
answer
within
minut
sampl
introduc
autom
import
improv
speed
provid
user
friendli
experi
sever
group
publish
review
articl
pointofcar
infecti
diseas
diagnosi
exampl
lee
et
al
review
nanomicrofluid
infecti
diseas
diagnost
techniqu
focu
onchip
detect
imag
count
chin
et
al
summar
current
pointofcar
devic
special
fluidic
handl
resourcelimit
set
uniqu
need
design
rule
develop
countri
emphas
park
et
al
discuss
microfluid
platform
diseas
diagnosi
use
onchip
pcr
innov
consum
electron
may
profound
impact
pointofcar
diagnosi
thoma
et
al
discuss
consum
electron
could
affect
pointofcar
technolog
propos
potenti
integr
two
subsequ
section
review
current
stateoftheart
technolog
pointofcar
devic
analysi
sever
import
viral
infecti
diseas
focu
fulli
integr
system
blood
sampl
hiv
remain
one
world
signific
public
health
challeng
claim
million
live
accord
transmit
cellfre
viru
directli
cell
via
celltocel
contact
howev
celltocel
transmiss
cell
effici
rapidli
transmit
predominantli
found
lymphoid
tissu
major
viru
viral
entri
involv
direct
fusion
viral
plasma
cell
membran
allow
viral
core
enter
cytoplasm
target
cell
first
hiv
envelop
glycoprotein
env
bind
receptor
first
chemokin
receptor
hiv
strain
hiv
strain
use
hiv
particl
activ
membran
insid
hiv
particl
may
follow
differ
pathway
either
secret
case
transcytosi
degrad
fuse
vesicl
inject
viral
core
cytoplasm
initi
infecti
viral
cycl
involv
synthesi
new
hiv
particl
use
hiv
dna
direct
synthesi
viral
rna
protein
assembl
hiv
particl
cytoplasm
final
viral
escap
cell
bud
cell
membran
often
kill
cell
process
enzym
immunoassay
eia
elisa
test
use
blood
oral
fluid
urin
detect
hiv
antibodi
common
test
hiv
screen
result
test
take
week
posit
elisa
result
confirm
anoth
immunolog
assay
western
blot
take
anoth
count
fewer
indic
advanc
diseas
one
qualif
diagnosi
aid
acquir
immun
defici
one
seriou
viral
infecti
diseas
hiv
diagnosi
investig
integr
labonchip
system
western
blot
one
standard
method
detect
protein
hugh
et
al
integr
western
blot
microfluid
devic
includ
step
enrich
separ
immobil
antibodi
probe
fig
devic
success
integr
convent
blot
techniqu
benchtop
handheld
devic
also
maintain
compar
perform
pm
detect
limit
dynam
rang
within
h
feasibl
demonstr
hiv
detect
directli
perform
patient
whole
blood
report
kim
et
al
hiv
within
fingerprick
patient
blood
sampl
transport
microfluid
devic
neutravidin
surfac
coat
incub
min
immobil
hiv
label
two
type
quantum
dot
differ
color
biotinyl
antibodi
lectin
dual
label
process
made
direct
observ
possibl
fluoresc
microscop
magnif
paper
devic
design
made
oper
rel
easi
use
electron
autopipett
load
sampl
reagent
altern
possibl
manual
process
consid
practic
onsit
detect
paperbas
microfluid
devic
report
monitor
realtim
liver
function
hiv
patient
drug
treatment
fig
level
serum
transaminas
aspart
aminotransferas
ast
alanin
aminotransferas
alt
determin
import
patient
antivir
therapi
tuberculosi
andor
hiv
devic
stack
multipl
layer
top
protect
lamin
polyest
film
central
hole
blood
sampl
introduct
plasma
separ
membran
separ
blood
plasma
blood
cell
two
layer
pattern
hydrophil
paper
reconstitut
dri
reagent
detect
specif
target
paper
whatman
chromatographi
paper
pattern
use
wax
printer
xerox
aqueou
flow
guidanc
three
colorimetr
assay
creat
three
differ
locat
paper
pressuresensit
adhes
appli
paper
screenprint
variou
layer
bond
benchtop
lamin
total
blood
serum
sampl
load
assay
finish
min
perform
devic
overal
assay
compar
autom
instrument
devic
consid
green
chip
ie
use
dispos
inciner
avoid
hazard
wast
contamin
environ
chin
et
al
develop
mchip
assay
perform
clinic
hiv
syphili
diagnosi
rwanda
miniatur
benchtop
elisa
multitask
microfluid
devic
function
resourcelimit
set
util
polystyren
cyclic
olefin
copolym
devic
materi
devic
manufactur
scale
throughput
one
chip
everi
materi
cost
low
maintain
high
fabric
precis
develop
bubblebas
method
enabl
autom
deliveri
multipl
reagent
multistep
reaction
onchip
elisa
signal
amplif
detect
took
place
insid
meander
channel
silver
ion
reduc
onto
gold
nanoparticl
form
immunosandwich
complex
densiti
silvergold
complex
measur
lightemit
diod
photodetector
incorpor
inexpens
per
unit
userfriendli
compact
devic
jordan
et
al
design
anoth
platform
resourcelimit
set
use
magnet
heat
block
pipett
hiv
could
diagnos
use
dri
blood
spot
db
sampl
infant
helicasedepend
amplif
hda
assay
influenza
caus
annual
epidem
peak
autumn
winter
season
temper
region
ill
result
hospit
death
mainli
among
highrisk
group
includ
young
elderli
chronic
ill
worldwid
annual
epidem
result
three
million
case
sever
ill
epidem
take
econom
toll
lost
workforc
product
due
absent
worker
strain
health
servic
three
type
season
type
influenza
virus
pose
seriou
threat
among
three
subtyp
categor
subtyp
accord
differ
kind
combin
viru
surfac
protein
among
mani
subtyp
influenza
virus
circul
among
human
two
major
surfac
spike
glycoprotein
hemagglutinin
ha
neuraminidas
na
present
surfac
viru
ha
respons
mediat
entri
target
cell
via
host
cell
receptor
sialic
acid
sa
wherea
na
play
major
role
bud
process
releas
progeni
virion
host
although
avian
influenza
infect
human
strain
caus
sever
diseas
peopl
major
human
case
associ
direct
indirect
contact
infect
live
dead
poultri
studi
focus
season
circul
virus
found
avian
human
virus
differ
two
posit
surfac
ha
protein
respons
bind
clinic
manifest
serv
mean
tent
diagnosi
confirm
test
viral
isol
serolog
test
rapid
antigen
test
molecular
implement
differenti
possibl
viral
bacteri
infect
yearli
season
global
epidem
influenza
anoth
viru
receiv
wide
attent
pointofcar
diagnosi
prakash
et
al
develop
handheld
electroactu
base
droplet
microfluid
dmf
resist
microheat
temperatur
sensor
influenza
viru
qpcr
detect
hydrophob
circuitintegr
surfac
abl
manipul
droplet
contain
rna
qpcr
reaction
mixtur
compar
convent
realtim
revers
transcript
polymeras
chain
reaction
qrtpcr
equip
appli
biosystem
devic
compar
process
time
min
accept
effici
detect
vitro
synthes
influenza
rna
detect
limit
chipbas
qrtpcr
techniqu
copi
templat
rna
per
pcr
reaction
pointofcar
platform
develop
ferguson
et
al
influenza
detect
fig
sampl
prepar
mix
swab
sampl
antibodi
modifi
magnet
bead
incub
offchip
insid
mixtur
target
viru
captur
magnet
bead
modifi
antibodi
specif
viru
mixtur
load
microfluid
system
sequenc
procedur
includ
purif
pcr
amplif
electrochem
detect
perform
upstream
region
devic
virusmagnet
bead
complex
concentr
immobil
surfac
substrat
use
extern
magnet
field
meanwhil
wash
media
rtpcr
reagent
ad
sequenti
pdm
defin
microfluid
devic
wash
unbound
supernat
perform
rna
amplif
min
product
rtpcr
transport
downstream
part
devic
electrochem
detect
detect
limit
abe
et
al
integr
portabl
easytous
influenza
detect
system
use
loopmedi
isotherm
amplif
lamp
integr
system
abl
detect
influenza
within
buffer
solut
min
accuraci
reichmuth
et
al
concentr
detect
influenza
viru
polyacrylamid
gel
perform
electrophoresi
onchip
viru
sampl
mix
antibodi
load
microfluid
devic
electrophoresi
use
extern
platinum
electrod
viru
sampl
purifi
concentr
insid
polyacrylamid
gel
detect
epifluoresc
microscopi
less
sampl
total
process
complet
less
min
detect
limit
droplet
manipul
platform
avian
flu
detect
develop
pipper
et
al
fig
total
volum
nl
need
includ
sampl
droplet
reagent
droplet
contain
rna
magnet
particl
complex
place
perfluorin
surfac
manipul
droplet
extern
magnet
field
process
includ
purifi
wash
thermal
cycl
perform
rtqpcr
analysi
procedur
appli
onchip
target
rna
detect
volum
droplet
sever
microlit
reaction
time
reagent
consumpt
could
decreas
result
show
throat
swab
sampl
could
detect
min
pcr
effici
compar
offchip
procedur
faster
process
time
cheaper
cost
onchip
viru
sequenc
devic
integr
liu
et
al
combimatrix
dna
microarray
integr
microfluid
devic
automat
solut
handl
mix
flow
transport
devic
compat
fluoresc
scanner
demonstr
onchip
sequenc
rna
influenza
viru
h
viral
hepat
group
infecti
diseas
affect
hundr
million
peopl
hepat
hav
hbv
hcv
respect
directli
infect
hepatocyt
trigger
similar
acut
diseas
symptomat
patient
although
display
differ
mode
infect
level
hepat
b
c
lead
chronic
hepat
particularli
preval
million
peopl
chronic
infect
hepat
b
million
peopl
antibodi
hepat
partli
result
success
vaccin
cell
entri
mechan
hav
poorli
understood
infer
picornavirus
due
atyp
characterist
divers
entri
mode
use
member
incom
hbv
virion
bound
cellsurfac
receptor
ident
still
remain
hcv
envelop
glycoprotein
interact
directli
two
receptor
requir
tight
junction
compon
occludin
permit
hcv
blood
sampl
test
hepat
b
surfac
antigen
hbeag
antibodi
hbeag
igm
antibodi
hepat
b
core
antigen
igm
antihbc
elisa
clinic
diagnosi
presenc
hepat
b
surfac
antigen
serum
month
longer
indic
chronic
hepat
b
similarli
hepat
c
core
antigen
hcvcoreag
antihcv
antibodi
test
hbv
hcv
diagnosi
may
involv
biopsi
sampl
initi
assess
sever
complet
labonchip
system
report
hepat
diagnosi
fulli
automat
system
develop
lee
et
al
hepat
b
detect
devic
capabl
elisa
analysi
whole
blood
cdformat
platform
gener
centrifug
forc
transport
sampl
requir
reagent
devic
compar
perform
convent
elisa
detect
limit
detect
rang
process
time
reduc
h
min
requir
half
sampl
fig
krau
et
al
perform
onchip
elisa
hepat
c
hcv
detect
signal
enhanc
techniqu
target
antihcv
core
immunoglobulin
captur
gold
electrod
signal
amplif
enabl
enzym
label
singl
electrod
redox
cycl
process
approach
improv
signaltonois
ratio
fold
process
time
fold
compar
standard
oxid
microlit
plate
base
elisa
sensit
compar
convent
elisa
nl
expens
antigen
need
contrast
convent
elisa
dengu
mosquitoborn
infect
found
tropic
subtrop
region
around
world
howev
recent
year
transmiss
extend
urban
area
becom
major
intern
public
health
current
estim
million
dengu
infect
occur
worldwid
everi
year
although
close
relat
four
distinct
serotyp
viru
caus
dengu
upon
bitten
infect
femal
aedesaegypti
mosquito
virion
attach
host
cell
surfac
receptor
enter
cell
via
receptormedi
fusion
viral
cellular
membran
occur
result
conform
chang
e
protein
viral
surfac
trigger
acid
environ
endosom
viral
dna
releas
cytoplasm
viral
genom
rna
translat
blood
sampl
test
igm
antibodi
dengu
viru
envelop
protein
antigen
elisa
clinic
magnet
bead
base
approach
develop
lee
et
al
dengu
viru
detect
dengu
virion
specif
immunoglobulin
detect
dengu
virion
detect
viru
suspens
mix
magnet
bead
insid
micromix
unbound
substanc
wash
magnet
field
appli
virusmagnet
bead
complex
releas
transport
micropump
flow
cytomet
detect
immunoglobulin
detect
onchip
elisa
immobil
magnet
bead
detect
limit
pg
min
zaytseva
et
al
develop
devic
dengu
rna
detect
target
dengu
rna
bound
magnet
bead
liposom
dna
captur
report
probe
respect
insid
microfluid
channel
liposom
serv
fluoresc
signal
amplifi
detect
process
oper
continu
flow
could
complet
min
sar
viral
respiratori
ill
caus
coronaviru
infect
total
peopl
two
dozen
countri
north
america
south
america
europ
asia
viral
envelop
glycoprotein
spike
bind
host
cell
receptor
trigger
conform
chang
protein
lead
cleavag
protein
host
cell
proteas
viral
unlik
mani
virus
previous
discuss
sar
new
diseas
human
elisa
test
commonli
use
detect
virus
report
inconsist
detect
antibodi
sar
day
onset
laboratori
test
sar
use
revers
transcript
rt
pcr
assay
amplifi
replicas
abpolymeras
gene
coronaviru
variou
sampl
includ
blood
stool
respiratori
secret
bodi
symptom
earli
stage
sar
similar
influenza
result
consequ
pcr
standard
method
rapid
accur
sar
diagnosi
necessari
base
high
morbid
mortal
rate
zhou
et
al
integr
pcr
microfluid
devic
sar
diagnosi
sampl
manipul
via
capillari
electrophoresi
thermal
cycl
perform
peltier
devic
pcr
product
analyz
offchip
engin
eppendorf
tube
develop
sar
detect
fig
tube
perform
pcr
dna
microarray
one
batch
without
reopen
tube
cap
dna
microarray
pattern
eppendorf
cap
pcr
complet
tube
turn
start
reaction
prepattern
microarray
addit
sar
devic
also
demonstr
detect
influenza
ab
enteroviru
fals
posit
fals
neg
diagnosi
identifi
possibl
sudden
viral
infecti
diseas
outbreak
consequ
global
spread
lead
devast
impact
societi
economi
press
need
develop
new
method
earli
diagnosi
pathogen
afford
effect
popul
screen
realtim
treatment
monitor
pointofcar
microdevic
demonstr
potenti
fulfil
assur
criteria
sensit
specif
lowcost
rapid
portabl
access
past
decad
labonchip
technolog
viral
infecti
diseas
develop
activ
singl
devic
compon
complet
system
onchip
promis
approach
chang
clinic
practic
viral
infecti
diseas
manag
near
futur
although
labonchip
microdevic
explor
viral
infecti
diseas
still
signific
challeng
overcom
well
opportun
worthwhil
investig
test
clinic
sampl
addit
pure
sampl
water
pb
devic
need
valid
artifici
construct
sampl
ie
target
known
concentr
spike
blood
plasmasera
healthi
donor
control
condit
success
artifici
construct
sampl
critic
mileston
technolog
develop
larg
dynam
rang
viral
biomark
artifici
construct
sampl
evalu
ensur
clinic
sensit
specif
achiev
next
clinic
deriv
sampl
clinic
studi
microdevic
requir
translat
technolog
medic
practic
compar
artifici
spikein
sampl
clinic
patient
sampl
higher
degre
uncertainti
target
concentr
interfer
speci
exampl
differ
target
virusbiomark
immunoglobulin
concentr
less
predict
among
human
subject
variat
immun
respons
diet
prefer
treatment
histori
among
patient
thu
better
perform
sensit
specif
dynam
rang
might
requir
microdevic
avoid
high
falseposit
falseneg
result
clinic
test
argument
favor
test
larg
number
clinic
sampl
statist
data
analysi
howev
also
nontechn
hurdl
import
clinic
studi
distribut
commerci
pointofcar
technolog
current
devic
prototyp
fabric
insid
research
lab
order
fulli
util
daili
basi
wide
accept
clinic
set
prototyp
must
develop
consum
product
exampl
fabric
process
need
transform
batch
process
necessari
devic
instrument
reliabl
robust
automat
userfriendli
like
joint
effort
academia
industri
govern
overal
process
also
depend
medic
need
readi
commerci
strategi
market
accept
addit
technolog
near
futur
base
progress
made
among
variou
research
field
imagin
detail
analys
beyond
simpl
viral
detect
exampl
genom
sequenc
viru
determin
rapidli
onchip
identifi
viru
track
mutat
evolut
similar
bacteria
cultur
antibiot
screen
person
drug
respons
test
viral
infecti
diseas
may
improv
efficaci
viral
drug
treatment
technolog
side
new
function
materi
carbon
nanomateri
biodegrad
polym
potenti
break
barrier
achiev
higher
sensit
select
speed
addit
effici
miniatur
macroscop
viral
detect
system
may
provid
shortcut
improv
perform
micro
nano
scale
today
develop
pointofcar
microdevic
viral
infecti
diseas
activ
field
promis
realiz
potenti
prevent
viru
spread
significantli
improv
clinic
diagnosi
treatment
viral
infecti
diseas
